======= CDK10 ======= == Gene Information == * **Official Symbol**: CDK10 * **Official Name**: cyclin dependent kinase 10 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=8558|8558]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q15131|Q15131]] * **Interactions**: [[https://thebiogrid.org/search.php?search=CDK10&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CDK10|Open PubMed]] * **OMIM**: [[https://omim.org/entry/603464|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: N/A |Pkinase| |Pkinase Tyr| |traversing start control point of mitotic cell cycle| |negative regulation of cilium assembly| |negative regulation of plasma membrane bounded cell projection assembly| |cyclin-dependent protein serine/threonine kinase activity| |positive regulation of G1/S transition of mitotic cell cycle| |negative regulation of organelle assembly| |positive regulation of cell cycle G1/S phase transition| |positive regulation of mitotic cell cycle phase transition| |regulation of cilium assembly| |peptidyl-threonine phosphorylation| |peptidyl-threonine modification| |positive regulation of cell cycle phase transition| |ciliary basal body| |regulation of G1/S transition of mitotic cell cycle| |positive regulation of mitotic cell cycle| |regulation of cell cycle G1/S phase transition| |negative regulation of cell projection organization| |regulation of plasma membrane bounded cell projection assembly| |regulation of cell projection assembly| |regulation of organelle assembly| |positive regulation of cell cycle process| |regulation of actin cytoskeleton organization| |protein serine/threonine kinase activity| |negative regulation of organelle organization| |positive regulation of cell cycle| |regulation of actin filament-based process| |regulation of mitotic cell cycle phase transition| |regulation of cell cycle phase transition| |regulation of cytoskeleton organization| |positive regulation of MAPK cascade| |regulation of mitotic cell cycle| |negative regulation of cell population proliferation| |regulation of plasma membrane bounded cell projection organization| |negative regulation of cellular component organization| |regulation of cell projection organization| |regulation of MAPK cascade| |regulation of cell cycle process| |peptidyl-amino acid modification| |regulation of cellular component biogenesis| |protein phosphorylation| |positive regulation of protein phosphorylation| |positive regulation of intracellular signal transduction| |positive regulation of phosphorylation| |positive regulation of phosphorus metabolic process| |positive regulation of phosphate metabolic process| |cell projection organization| |regulation of cell cycle| |positive regulation of protein modification process| |phosphorylation| |regulation of organelle organization| |regulation of protein phosphorylation| |ATP binding| |regulation of phosphorylation| |positive regulation of cellular protein metabolic process| |regulation of cell population proliferation| |positive regulation of signal transduction| |positive regulation of protein metabolic process| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |regulation of protein modification process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp444|THZ531 0.225μM R08 exp444]]|-3.56| |[[:results:exp410|THZ531 0.11 to 0.125μM on day4 R07 exp410]]|-3.35| |[[:results:exp412|THZ531 0.11 to 0.125 to 0.35μM on day4 then day6 R07 exp412]]|-3| |[[:results:exp413|THZ531 0.11 to 0.175μM on day4 R07 exp413]]|-2.92| |[[:results:exp409|THZ531 0.11μM R07 exp409]]|-2.73| |[[:results:exp335|Aminopterin 0.005μM R07 exp335]]|-1.87| |[[:results:exp501|Methotrexate 0.01μM R08 exp501]]|-1.72| |[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|1.82| |[[:results:exp334|All-trans-Retinoic-Acid 40μM R07 exp334]]|1.85| |[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|1.89| |[[:results:exp35|TRAIL 5ng/ml R00 exp35]]|1.96| |[[:results:exp485|GSK626616 14μM R08 exp485]]|2.23| |[[:results:exp83|Trametinib 10μM R02 exp83]]|2.75| |[[:results:exp66|BI-D1870 3.15μM R02 exp66]]|3.35| ^Gene^Correlation^ |[[:human genes:f:fam58a|FAM58A]]|0.681| |[[:human genes:t:ttc14|TTC14]]|0.643| |[[:human genes:c:ccnk|CCNK]]|0.434| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 2602 * **Expression level (log2 read counts)**: 6.43 {{:chemogenomics:nalm6 dist.png?nolink |}}